Allstate Corp vs Ascendis Pharma A/S — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). The key difference: Allstate Corp is far larger — about 4× Ascendis Pharma A/S's market cap, and Allstate Corp pays a 1.65% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ALL | ASND | |
|---|---|---|
Market Cap | $66.31B | $16.67B |
Sector | Financials | Health |
52-Week High | $275.11 | $277.18 |
52-Week Low | $190.00 | $189.74 |
Enterprise Value | $74.96B | $17.04B |
Dividend Yield | 1.65% | — |
Trailing returns across standard periods
Latest headlines on both assets
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →